![]() |
Name |
Penicamedine A
|
Molecular Formula | C21H22N2O7 | |
IUPAC Name* |
(1R,2R,3S,4R,5S,9R)-5-acetyl-3,4,5-trihydroxy-8,8,16-trimethyl-19-oxa-7,16-diazahexacyclo[9.6.1.11,4.02,9.03,7.015,18]nonadeca-11(18),12,14-triene-6,17-dione
|
|
SMILES |
CC(=O)[C@]1(C(=O)N2[C@]3([C@@]1(O[C@]45[C@H]3[C@H](C2(C)C)CC6=C4C(=CC=C6)N(C5=O)C)O)O)O
|
|
InChI |
InChI=1S/C21H22N2O7/c1-9(24)19(27)16(26)23-17(2,3)11-8-10-6-5-7-12-13(10)18(15(25)22(12)4)14(11)20(23,28)21(19,29)30-18/h5-7,11,14,27-29H,8H2,1-4H3/t11-,14-,18+,19-,20+,21-/m1/s1
|
|
InChIKey |
QLOOWQVCXQPADP-UMHNQWNOSA-N
|
|
Synonyms |
Penicamedine A; Speradine F
|
|
CAS | NA | |
PubChem CID | 139587045 | |
ChEMBL ID | NA |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 414.4 | ALogp: | -1.0 |
HBD: | 3 | HBA: | 7 |
Rotatable Bonds: | 1 | Lipinski's rule of five: | Accepted |
Polar Surface Area: | 128.0 | Aromatic Rings: | 6 |
Heavy Atoms: | 30 | QED Weighted: | 0.529 |
Caco-2 Permeability: | -5.42 | MDCK Permeability: | 0.00000654 |
Pgp-inhibitor: | 0.883 | Pgp-substrate: | 0.032 |
Human Intestinal Absorption (HIA): | 0.672 | 20% Bioavailability (F20%): | 0.983 |
30% Bioavailability (F30%): | 0.99 |
Blood-Brain-Barrier Penetration (BBB): | 0.773 | Plasma Protein Binding (PPB): | 70.13% |
Volume Distribution (VD): | 1.04 | Fu: | 30.77% |
CYP1A2-inhibitor: | 0.007 | CYP1A2-substrate: | 0.288 |
CYP2C19-inhibitor: | 0.097 | CYP2C19-substrate: | 0.952 |
CYP2C9-inhibitor: | 0.229 | CYP2C9-substrate: | 0.006 |
CYP2D6-inhibitor: | 0.001 | CYP2D6-substrate: | 0.067 |
CYP3A4-inhibitor: | 0.156 | CYP3A4-substrate: | 0.953 |
Clearance (CL): | 2.112 | Half-life (T1/2): | 0.47 |
hERG Blockers: | 0.002 | Human Hepatotoxicity (H-HT): | 0.305 |
Drug-inuced Liver Injury (DILI): | 0.975 | AMES Toxicity: | 0.14 |
Rat Oral Acute Toxicity: | 0.394 | Maximum Recommended Daily Dose: | 0.922 |
Skin Sensitization: | 0.391 | Carcinogencity: | 0.879 |
Eye Corrosion: | 0.003 | Eye Irritation: | 0.008 |
Respiratory Toxicity: | 0.022 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC006111 | ![]() |
0.315 | D08NQZ | ![]() |
0.262 | ||
ENC003506 | ![]() |
0.307 | D0J2NK | ![]() |
0.239 | ||
ENC006109 | ![]() |
0.280 | D0R6RC | ![]() |
0.239 | ||
ENC005510 | ![]() |
0.279 | D05AFR | ![]() |
0.236 | ||
ENC006110 | ![]() |
0.274 | D02IQY | ![]() |
0.236 | ||
ENC003035 | ![]() |
0.271 | D0P0HT | ![]() |
0.236 | ||
ENC001387 | ![]() |
0.263 | D02NSF | ![]() |
0.235 | ||
ENC003549 | ![]() |
0.263 | D0W7RJ | ![]() |
0.234 | ||
ENC004284 | ![]() |
0.261 | D06TQZ | ![]() |
0.230 | ||
ENC005071 | ![]() |
0.261 | D03SKD | ![]() |
0.229 |